Treatment of supraventricular tachycardias in the new millennium--drugs or radiofrequency catheter ablation?

Bauersfeld, U; Pfammatter, Jean-Pierre; Jaeggi, Edgard

doi:10.1007/PL00008409

Scientific article

Review

English

Treatment of supraventricular tachycardias in the new millennium--drugs or radiofrequency catheter ablation?

ContributorsBauersfeld, U; Pfammatter, Jean-Pierre; Jaeggi, Edgard

Published inEuropean journal of pediatrics, vol. 160, no. 1, p. 1-9

Publication date2001

Abstract

Supraventricular tachycardias are a cause of significant morbidity in children. Newer anti-arrhythmic drugs and the invention of radiofrequency catheter ablation have revolutionised anti-arrhythmic therapy in children.

Keywords

Anti-Arrhythmia Agents/therapeutic use
Catheter Ablation
Child
Humans
Tachycardia, Supraventricular/physiopathology/therapy

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique

Citation (ISO format)

BAUERSFELD, U, PFAMMATTER, Jean-Pierre, JAEGGI, Edgard. Treatment of supraventricular tachycardias in the new millennium--drugs or radiofrequency catheter ablation? In: European journal of pediatrics, 2001, vol. 160, n° 1, p. 1–9. doi: 10.1007/PL00008409

Article (Published version)

Identifiers

PID : unige:72780
DOI : 10.1007/PL00008409
PMID : 11195011

Journal ISSN0340-6199

494views

0downloads

Creation06/05/2015 12:36:00

First validation06/05/2015 12:36:00

Update time15/03/2023 00:18:59

Status update15/03/2023 00:18:59

Last indexation31/10/2024 01:18:42

Archive ouverte UNIGE

Treatment of supraventricular tachycardias in the new millennium--drugs or radiofrequency catheter ablation?

Supraventricular tachycardias are a cause of significant morbidity in children. Newer anti-arrhythmic drugs and the invention of radiofrequency catheter ablation have revolutionised anti-arrhythmic therapy in children.

Technical informations